Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/9/06 → 03/31/11 |
Funding
- Pfizer Incorporated: $5,685.27
26-Week Open-Label Extension Study Evaluating The Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Adolescent Subjects with Schizophrenia
- Kaye, David (PI)
- Cummings, Michael (CoI)
- Waxmonsky, James (CoI)
Project: Research